Join Now
Sign In
Theresa Guise, MD
TheresaGuiseMD (Physician - Oncology - Hematology/Oncology (Verified) )| Communities: All Cancers | Answers: 0 |
| Member Since: Jun. 2012 |
Ask TheresaGuiseMD a question:
0
Cc:
Twitter
Facebook
Professional Statement
Theresa A. Guise, M.D., professor of medicine and Jerry W. and Peg S. Throgmartin professor of oncology in the Division of Endocrinology at the Indiana University School of Medicine.
Dr. Guise’s principal laboratory interests encompass skeletal complications of malignancy: tumor metastasis to bone and the effect of cancer treatment on skeletal health. Specifically, she studies the molecular mechanisms by which tumor cells interact with bone cells to cause either bone destruction (osteolytic metastases) or new bone formation (osteoblastic metastases) using mouse models. The effect of cancer treatments, such as androgen deprivation for prostate cancer and aromatase inhibitors for breast cancer, on bone mass as well as the development and progression of bone metastasis is under investigation. In these areas, she is currently involved as principal investigator in several grant-funded research projects from the NIH and the Department of Defense.
Dr. Guise’s clinical interests encompass diseases of calcium and bone metabolism, and she is Principal Investigator on several clinical trials. She was elected to the American Society for Clinical Investigation in 2004 and is a permanent member of the NIH study section of Skeletal Biology, Structure and Regeneration.
Dr. Guise’s principal laboratory interests encompass skeletal complications of malignancy: tumor metastasis to bone and the effect of cancer treatment on skeletal health. Specifically, she studies the molecular mechanisms by which tumor cells interact with bone cells to cause either bone destruction (osteolytic metastases) or new bone formation (osteoblastic metastases) using mouse models. The effect of cancer treatments, such as androgen deprivation for prostate cancer and aromatase inhibitors for breast cancer, on bone mass as well as the development and progression of bone metastasis is under investigation. In these areas, she is currently involved as principal investigator in several grant-funded research projects from the NIH and the Department of Defense.
Dr. Guise’s clinical interests encompass diseases of calcium and bone metabolism, and she is Principal Investigator on several clinical trials. She was elected to the American Society for Clinical Investigation in 2004 and is a permanent member of the NIH study section of Skeletal Biology, Structure and Regeneration.
Professional Info
Credential: MD
Primary specialty: Oncology - Hematology/Oncology
Secondary specialty: Endocrinology
Medical school: University of Pittsburgh School of Medicine
Residency: University Pittsburgh Health Center
Fellowship: University Texas Health Science Center
Areas of expertise: Effects of Cancer and Cancer Treatment on Bone, Bone Metastases, Osteoporosis. Pagets Disease
Research interests: Our current research program encompasses skeletal complications of cancer and cancer therapy. Funded programs include those on TGFbeta signaling and bone metastases, role of hypoxia in bone metastases, adrenomedullin in bone metastases, endothelins in pathological and normal bone remodeling.
Hospital affiliation: Indiana University Melvin and Bren Simon Cancer Center
Practice address:
980 W. Walnut Street R3 C132
Indianapolis, IN
46202
Practice phone number: (317) 278-6012
TheresaGuiseMD's Profile
Newsletters
Sign up for email updates of the latest news, best answers, and featured experts.
Benefits
Custom health, wellness, & medical offers including clinical trials, market research opportunities, & new programs.
Share TalkAboutHealth
To share TalkAboutHealth with friends, type their email addresses here (separated by commas):
From:
Add a personal note here:
Please join TalkAboutHealth and you will be able to ask questions.
Your question to TheresaGuiseMD:
2) Background Info (optional): What context or background information is relevant to this request?
Notes:
The more clear and thorough your request, the more likely you will receive support.
Many of our members are learning from this information or english might not be their first language. Please use standard english and spell out all words. For example, use 'you' instead of 'u'.
The more clear and thorough your request, the more likely you will receive support.
Many of our members are learning from this information or english might not be their first language. Please use standard english and spell out all words. For example, use 'you' instead of 'u'.
Newsletters
